Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells

AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular disease

(2010) Chunying Li et al.   CURRENT OPINION IN PHARMACOLOGY

Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway

(2009) Liang-qi Cao et al.   ACTA PHARMACOLOGICA SINICA

Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: A crucial role of AMPK and mTOR pathways

(2009) Po-Cheng Chiang et al.   BIOCHEMICAL PHARMACOLOGY

Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma

(2009) Huamao Wang et al.   CANCER LETTERS

Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress

(2009) Hee-Yeon Cho et al.   CANCER LETTERS

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

(2009) Yohei Shirakami et al.   CANCER SCIENCE

Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation

(2009) Kaufmann   ONCOLOGY REPORTS

Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

(2008) Adriana Sergio et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells

(2008) Masahito Shimizu et al.   CANCER LETTERS

Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer

(2008) J. B. Tuynman et al.   CANCER RESEARCH

Mechanisms of Action and Resistance of Somatostatin Analogues for the Treatment of Hepatocellular Carcinoma: A Message Not Well Taken

(2008) Dimitrios N. Samonakis et al.   DIGESTIVE DISEASES AND SCIENCES

Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib

(2008) Huahong Xie et al.   MOLECULAR CARCINOGENESIS

Evolution of systemic therapy of advanced hepatocellular carcinoma

(2008) Thomas Yau et al.   WORLD JOURNAL OF GASTROENTEROLOGY